Press Room

Press Clipping / Jan 25, 2019

Fire Services Bureau holds emergency drill at Hovione plant in Taipa

Macau News Agency, January 25, 2019

The Fire Services Bureau held an emergency drill at the Hovione pharmaceutical plant in Taipa, to better strengthen the resilience and coordination of the bureau, and about 150 personnel from both parties participated.

Macau Factory | Hovione

Macau (MNA) – The Fire Services Bureau (CB) on Thursday held an emergency drill at the Hovione PharmaScience Ltd Plant (Hovione) in Taipa, to better strengthen the resilience and coordination of the bureau.

According to a release by the CB, the drill simulated an accident occurring when a worker operating a forklift at the pharmaceutical plant pierced a methanol solvent storage tank and caused a fire.

During the evacuation process of the drill, workers pretended to be injured while the remainder of the staff took safety measures in accordance with the internal contingency plan of the plant, and evacuated all relevant personnel to their emergency meeting point.

When informed of the ‘accident’, the CB dispatched nine emergency vehicles and 37 firefighters to the scene who carried out fire fighting, evacuations, search and rescue, as well as caring for the injured, according to an established plan.

The exercise lasted for about an hour, and a total of 150 personnel from both Hovione and the CB participated in the exercise.

The release states that the drill went smoothly and achieved its intended purpose, and after its completion, a meeting took place between both parties to discuss future exercises in testing their responses.

 

Read complete article at MNA

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025